Literature DB >> 23570851

HIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness, and public health impact.

Connie Celum, Timothy B Hallett, Jared M Baeten.   

Abstract

Entities:  

Keywords:  HIV pre-exposure prophylaxis; antiretroviral therapy; public health impact; resistance

Mesh：

Substances：

Year:  2013        PMID： 23570851      PMCID： PMC3685227          DOI： 10.1093/infdis/jit154

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

Review 2.  Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review.

Authors:  Kathryn M Stadeli; Douglas D Richman
Journal:  Antivir Ther       Date:  2012-10-10

3.  HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis.

Authors:  Virginie Supervie; J Gerardo García-Lerma; Walid Heneine; Sally Blower
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

4.  HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.

Authors:  Raph L Hamers; Carole L Wallis; Cissy Kityo; Margaret Siwale; Kishor Mandaliya; Francesca Conradie; Mariette E Botes; Maureen Wellington; Akin Osibogun; Kim C E Sigaloff; Immaculate Nankya; Rob Schuurman; Ferdinand W Wit; Wendy S Stevens; Michèle van Vugt; Tobias F Rinke de Wit
Journal:  Lancet Infect Dis       Date:  2011-07-27       Impact factor: 25.071

5.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa.

Authors:  Ume L Abbas; Robert Glaubius; Anuj Mubayi; Gregory Hood; John W Mellors
Journal:  J Infect Dis       Date:  2013-04-09       Impact factor: 5.226

8.  Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.

Authors:  Ravindra K Gupta; Michael R Jordan; Binta J Sultan; Andrew Hill; Daniel H J Davis; John Gregson; Anthony W Sawyer; Raph L Hamers; Nicaise Ndembi; Deenan Pillay; Silvia Bertagnolio
Journal:  Lancet       Date:  2012-07-23       Impact factor: 79.321
  8 in total
  20 in total

1.  Safety and tolerability of tenofovir for preexposure prophylaxis among men who have sex with men.

Authors:  Sten H Vermund
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

2.  Considering high alcohol and violence neighborhood context using daily diaries and GPS: A pilot study among people living with HIV.

Authors:  Katherine P Theall; Erica Felker-Kantor; Maeve Wallace; Xiao Zhang; Christopher N Morrison; Douglas J Wiebe
Journal:  Drug Alcohol Depend       Date:  2018-04-10       Impact factor: 4.492

3.  Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project.

Authors:  Susanne Doblecki-Lewis; Albert Liu; Daniel Feaster; Stephanie E Cohen; Gabriel Cardenas; Oliver Bacon; Erin Andrew; Michael A Kolber
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

4.  Syndemics and the PrEP Cascade: Results from a Sample of Young Latino Men Who Have Sex with Men.

Authors:  Aaron J Blashill; John P Brady; Benjamin M Rooney; Carlos E Rodriguez-Diaz; Keith J Horvath; Jill Blumenthal; Sheldon Morris; David J Moore; Steven A Safren
Journal:  Arch Sex Behav       Date:  2019-10-07

5.  Adherence to antiretroviral therapy among HIV-infected adults in the United States.

Authors:  Linda Beer; Jacek Skarbinski
Journal:  AIDS Educ Prev       Date:  2014-12

6.  Antiretroviral therapy for the prevention of HIV transmission: what will it take?

Authors:  Margaret L McNairy; Wafaa M El-Sadr
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079

Review 7.  Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy.

Authors:  Steven D Reid; Sarah J Fidler; Graham S Cooke
Journal:  Clin Epidemiol       Date:  2013-09-26       Impact factor: 4.790

8.  Projecting the number of new HIV infections to formulate the "Getting to Zero" strategy in Illinois, USA.

Authors:  Aditya Subhash Khanna; Mert Edali; Jonathan Ozik; Nicholson Collier; Anna Hotton; Abigail Skwara; Babak Mahdavi Ardestani; Russell Brewer; Kayo Fujimoto; Nina Harawa; John A Schneider
Journal:  Math Biosci Eng       Date:  2021-05-06       Impact factor: 2.080

9.  Estimating PMTCT's Impact on Heterosexual HIV Transmission: A Mathematical Modeling Analysis.

Authors:  Aditya S Khanna; Sarah T Roberts; Susan Cassels; Roger Ying; Grace John-Stewart; Steven M Goodreau; Jared M Baeten; Pamela M Murnane; Connie Celum; Ruanne V Barnabas
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

10.  Abriendo Puertas: baseline findings from an integrated intervention to promote prevention, treatment and care among FSW living with HIV in the Dominican Republic.

Authors:  Yeycy Donastorg; Clare Barrington; Martha Perez; Deanna Kerrigan
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.